🧾 What This Document Is

This is an 8-K filing, which is a report of major events that shareholders should know about. In this case, it's a press release attached as an exhibit, announcing the company's financial results for the last quarter and full year of 2025, and sharing some major operational news.

👉 Why it matters: This is the primary way the company communicates its performance and big moves to the public and investors.

🏢 What The Company Does

In simple terms, American Shared Hospital Services (AMS) helps hospitals and cancer centers get access to advanced, high-tech cancer treatment machines. They do this in two main ways:

Leasing Equipment: They own expensive machines like Gamma Knife and Proton Beam systems and lease them to hospitals.
Direct Patient Care: They actually run their own stand-alone cancer treatment centers where patients go for care.

👉 Why it matters: They are shifting their business model towards owning and operating the treatment centers, which is a more active (and operationally complex) role than just being a landlord for equipment.

💰 Financial Highlights: A Year of Transition

The big story for 2025 is that AMS shifted from making a profit to posting a loss, while its revenue mix changed dramatically.

Full Year 2025 vs. 2024:

Total Revenue: $28.1 million, down slightly from $28.3 million.
Net Loss: $(1.6) million or $(0.23) per share. This is a big change from net income of $2.2 million in 2024.
The Reason for the Swing: 2024's profit was boosted by a one-time $3.8 million gain from an acquisition. Without that, 2025's operational results were tougher.
Gross Margin Fell: Dropped to 18% from 32%. This means for every dollar of revenue, they kept less after direct costs, mainly because their newer patient care centers have lower margins than their old leasing business.

Business Segment Performance (Full Year):

Direct Patient Care (The Growth Engine): Revenue jumped 23.7% to $15.5 million. This segment now makes up over 55% of total revenue, driven by new centers in Rhode Island and Mexico.
Medical Equipment Leasing (The Headwind): Revenue fell to $12.6 million from $15.6 million. This was due to three expired Gamma Knife contracts and lower volumes at their Proton Beam system.

🚀 Key Moves & Operational News

The company isn't just reporting numbers; they're actively building their future.

Major Lease Extension: They secured a seven-year extension for their Proton Beam therapy system with Orlando Health, a partner for over 20 years. This locks in a key revenue stream through 2033.
Expansion in Rhode Island: They are building two new centers—a radiation therapy center in Bristol and a proton therapy center in Johnston. This deepens their footprint in a key market.
Technology Upgrades: Completed an upgrade of a Gamma Knife unit in Lima, Peru to the new "Esprit" platform, which can treat a wider range of conditions.

👉 Why it matters: These moves show they are investing in their future growth (new centers) while shoring up existing relationships (Orlando Health lease).

📦 Financial Position & Balance Sheet Health

This is a critical area of concern highlighted in the filing.

Cash Dwindled: Cash dropped from $11.3 million to $3.7 million. The big reason? $7.5 million spent on capital projects, like building the new Rhode Island centers.
Debt Situation: They have $17.3 million in debt coming due soon. Crucially, they did not meet certain financial covenants (rules set by their lender) as of year-end.
Ongoing Talks: Management says they are in "constructive discussions" with their lender to get waivers or change the loan terms.
Stock Price vs. Book Value: The stock trades at a big discount. Shareholders' equity (the book value) is $3.66 per share, but the stock price is much lower.

👉 Why it matters: The low cash and debt covenant issue create financial risk. Their ability to renegotiate with their lender is now a key watching point.

🔮 What's Next: The 2026 Playbook

Management's forward focus is clear:

Optimize Existing Centers: Get the most out of their current network of treatment centers.
Drive Growth in Rhode Island: The new centers there are central to their expansion plans.
Expand Internationally: They see the new Gamma Knife Esprit in Guadalajara, Mexico as a growth driver.
Fix the Balance Sheet: The ongoing discussions with their lender are a top priority to improve financial flexibility.

⚖️ Big Picture: Strengths & Risks

👍 Strengths:

Successful Strategic Shift: They are effectively growing their direct patient care revenue, which they believe offers more stable, long-term income.
Proven Partnerships: The long-term lease extension with Orlando Health shows strong, enduring hospital relationships.
Growth Pipeline: Approved plans for two new centers in Rhode Island provide a clear path for future expansion.

⚠️ Risks:

Financial Strain: Low cash and broken debt covenants pose immediate liquidity and compliance risks.
Profitability Pressure: Margins are being squeezed as the lower-margin patient care business becomes the majority of revenue.
Execution Risk: Successfully operating and filling multiple new centers while managing a complex business transition is challenging.
Vulnerable to Volume Fluctuations: Their business depends on patient treatment volumes, which can be cyclical, as seen with the Proton Beam therapy.

🧠 The Analogy

Imagine AMS is a landlord who decided to also open their own restaurant chain in the buildings they own. For a while, the rental income (equipment leasing) was great. But now, some tenants have moved out (expired contracts), while they're pouring cash and energy into building new restaurants (patient care centers). The restaurants are bringing in more total customers (revenue), but they're more expensive to run and are using up all their savings. Now, the bank is asking questions about their loan because the numbers don't look the same as when they were just a landlord.

📇 Key Contacts & People

Ray Stachowiak, Executive Chairman
- Email: [email protected]
Gary Delanois, Chief Executive Officer
Scott Frech, Chief Financial Officer
Kirin Smith, President, PCG Advisory, Inc. (Investor Relations)
- Email: [email protected]

Conference Call Details (March 31, 2026):

Domestic Dial-In: 1-844-413-3972
International Dial-In: 1-412-317-5776
Webcast Link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=QqZruHXQ
Replay (until April 7): 1-855-669-9658 or 1-412-317-0088, access code 6331493

🧩 Final Takeaway

AMS is in a classic "transition year" – strategically growing its future (direct care centers) at the cost of current profitability and cash. The major lease extension is a bright spot, but the immediate challenge is managing its strained balance sheet and proving this new model can generate stable profits.

AMERICAN SHARED HOSPITAL SERVICES — 8-K Filing